|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shah SA, Haddad R, Al-Sukhni W, Kim RD,
Greig PD, Grant DR, Taylor BR, Langer B, Gallinger S and Wei AC:
Surgical resection of hepatic and pulmonary metastases from
colorectal carcinoma. J Am Coll Surg. 202:468–475. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin PC, Lin JK, Lin CC, Wang HS, Yang SH,
Jiang JK, Lan YT, Lin TC, Li AF, Chen WS and Chang SC: Carbohydrate
antigen 19-9 is a valuable prognostic factor in colorectal cancer
patients with normal levels of carcinoembryonic antigen and may
help predict lung metastasis. Int J Colorectal Dis. 27:1333–1338.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cejas P, López-Gómez M, Aguayo C, Madero
R, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Moreno Garcia
V, Larrauri J, López R, et al: KRAS mutations in primary colorectal
cancer tumors and related metastases: A potential role in
prediction of lung metastasis. PLoS One. 4:e81992009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitry E, Guiu B, Cosconea S, Jooste V,
Faivre J and Bouvier AM: Epidemiology, management and prognosis of
colorectal cancer with lung metastases: A 30-year population-based
study. Gut. 59:1383–1388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Warwick R and Page R: Resection of
pulmonary metastases from colorectal carcinoma. Eur J Surg Oncol.
33 Suppl 2:S59–S63. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee WS, Yun SH, Chun HK, Lee WY and Yun H:
Clinical usefulness of chest radiography in detection of pulmonary
metastases after curative resection for colorectal cancer. World J
Surg. 31:1502–1506. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen D, Sun Q, Cheng X, Zhang L, Song W,
Zhou D, Lin J and Wang W: Genome-wide analysis of long noncoding
RNA (lncRNA) expression in colorectal cancer tissues from patients
with liver metastasis. Cancer Med. 5:1629–1639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
ENCODE Project Consortium, . An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arase M, Horiguchi K, Ehata S, Morikawa M,
Tsutsumi S, Aburatani H, Miyazono K and Koinuma D: Transforming
growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse
breast cancer JygMC(A) cells. Cancer Sci. 105:974–982. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang K, Long B, Zhou LY, Liu F, Zhou QY,
Liu CY, Fan YY and Li PF: CARL lncRNA inhibits anoxia-induced
mitochondrial fission and apoptosis in cardiomyocytes by impairing
miR-539-dependent PHB2 downregulation. Nat Commun.
5:35962014.PubMed/NCBI
|
|
15
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of lncRNA
AK126698 on cisplatin resistance in non-small-cell lung cancer
cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye LC, Zhu X, Qiu JJ, Xu J and Wei Y:
Involvement of long non-coding RNA in colorectal cancer: From
benchtop to bedside (Review). Oncol Lett. 9:1039–1045. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sargent DJ, Patiyil S, Yothers G, Haller
DG, Gray R, Benedetti J, Buyse M, Labianca R, Seitz JF, O'Callaghan
CJ, et al: End points for colon cancer adjuvant trials:
Observations and recommendations based on individual patient data
from 20,898 patients enrolled onto 18 randomized trials from the
ACCENT group. J Clin Oncol. 25:4569–4574. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guerrera F, Mossetti C, Ceccarelli M,
Bruna MC, Bora G, Olivetti S, Lausi PO, Solidoro P, Ciccone G,
Ruffini E, et al: Surgery of colorectal cancer lung metastases:
Analysis of survival, recurrence and re-surgery. J Thorac Dis.
8:1764–1771. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang P, Xu ZP, Chen T and He ZY: Long
noncoding RNA expression profile analysis of colorectal cancer and
metastatic lymph node based on microarray data. Onco Targets Ther.
9:2465–2478. 2016.PubMed/NCBI
|
|
22
|
Xue Y, Ma G, Gu D, Zhu L, Hua Q, Du M, Chu
H, Tong N, Chen J, Zhang Z and Wang M: Genome-wide analysis of long
noncoding RNA signature in human colorectal cancer. Gene.
556:227–234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang B, Li C and Zhao J: Identification
of key pathways and genes in colorectal cancer using bioinformatics
analysis. Med Oncol. 33:1112016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoekstra E, Das AM, Willemsen M, Swets M,
Kuppen PJ, van der Woude CJ, Bruno MJ, Shah JP, Ten Hagen TL,
Chisholm JD, et al: Lipid phosphatase SHIP2 functions as oncogene
in colorectal cancer by regulating PKB activation. Oncotarget.
7:73525–73540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arabzadeh A, Chan C, Nouvion AL, Breton V,
Benlolo S, DeMarte L, Turbide C, Brodt P, Ferri L and Beauchemin N:
Host-related carcinoembryonic antigen cell adhesion molecule 1
promotes metastasis of colorectal cancer. Oncogene. 32:849–860.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moench R, Grimmig T, Kannen V, Tripathi S,
Faber M, Moll EM, Chandraker A, Lissner R, Germer CT, Waaga-Gasser
AM and Gasser M: Exclusive inhibition of PI3K/Akt/mTOR signaling is
not sufficient to prevent PDGF-mediated effects on glycolysis and
proliferation in colorectal cancer. Oncotarget. 7:68749–68767.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peterson JE, Zurakowski D, Italiano JE Jr,
Michel LV, Connors S, Oenick M, D'Amato RJ, Klement GL and Folkman
J: VEGF, PF4 and PDGF are elevated in platelets of colorectal
cancer patients. Angiogenesis. 15:265–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuge R, Kitadai Y, Shinagawa K, Onoyama M,
Tanaka S, Yasui W and Chayama K: mTOR and PDGF pathway blockade
inhibits liver metastasis of colorectal cancer by modulating the
tumor microenvironment. Am J Pathol. 185:399–408. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Subramaniyan B, Jagadeesan K, Ramakrishnan
S and Mathan G: Targeting the interaction of Aurora kinases and
SIRT1 mediated by Wnt signaling pathway in colorectal cancer: A
critical review. Biomed Pharmacother. 82:413–424. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Y, Huang D, Wang Z, Wu C, Zhang Z,
Wang D, Li Z, Zhu T, Yang S and Sun W: LMO2 attenuates tumor growth
by targeting the Wnt signaling pathway in breast and colorectal
cancer. Sci Rep. 6:360502016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Xi Q and Wu G: Fatty acid synthase
regulates invasion and metastasis of colorectal cancer via Wnt
signaling pathway. Cancer Med. 5:1599–1606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen Y, Jiang T, Shi L and He K: hcrcn81
promotes cell proliferation through Wnt signaling pathway in
colorectal cancer. Med Oncol. 33:32016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu CL, Wang JZ, Xia XP, Pan CW, Shao XX,
Xia SL, Yang SX and Zheng B: Rab11-FIP2 promotes colorectal cancer
migration and invasion by regulating PI3K/AKT/MMP7 signaling
pathway. Biochem Biophys Res Commun. 470:397–404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang Y, Liu P, Tian Y, Xu Y, Ren F, Cui X
and Fan J: Overexpression of ribonuclease inhibitor defines good
prognosis and suppresses proliferation and metastasis in human
colorectal cancer cells via PI3K/AKT pathway. Clin Transl Oncol.
17:306–313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu M, Mu Y, Qi Y, Qin S, Qiu Y, Cui R and
Zhong M: Odontogenic ameloblast-associated protein (ODAM) inhibits
human colorectal cancer growth by promoting PTEN elevation and
inactivating PI3K/AKT signaling. Biomed Pharmacother. 84:601–607.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ke TW, Wei PL, Yeh KT, Chen WT and Cheng
YW: MiR-92a promotes cell metastasis of colorectal cancer through
PTEN-mediated PI3K/AKT pathway. Ann Surg Oncol. 22:2649–2655. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wei ZJ, Tao ML, Zhang W, Han GD, Zhu ZC,
Miao ZG, Li JY and Qiao ZB: Up-regulation of microRNA-302a
inhibited the proliferation and invasion of colorectal cancer cells
by regulation of the MAPK and PI3K/Akt signaling pathways. Int J
Clin Exp Pathol. 8:4481–4491. 2015.PubMed/NCBI
|
|
38
|
Huang M, Zhong Z, Lv M, Shu J, Tian Q and
Chen J: Comprehensive analysis of differentially expressed profiles
of lncRNAs and circRNAs with associated co-expression and ceRNA
networks in bladder carcinoma. Oncotarget. 7:47186–47200.
2016.PubMed/NCBI
|
